{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:33:33Z","timestamp":1773423213314,"version":"3.50.1"},"reference-count":0,"publisher":"OAE Publishing Inc.","content-domain":{"domain":["oaepublish.com"],"crossmark-restriction":false},"short-container-title":["CDR"],"published-print":{"date-parts":[[2018]]},"DOI":"10.20517\/cdr.2018.12","type":"journal-article","created":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T01:00:11Z","timestamp":1535590811000},"update-policy":"https:\/\/doi.org\/10.20517\/oae.crossmark.policy","source":"Crossref","is-referenced-by-count":4,"title":["Linking tyrosine kinase inhibitor-mediated inflammation with normal epithelial cell homeostasis and tumor therapeutic responses"],"prefix":"10.20517","author":[{"given":"Natalia J.","family":"Gurule","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn E.","family":"Heasley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8410","published-online":{"date-parts":[[2018]]},"container-title":["Cancer Drug Resistance"],"original-title":[],"link":[{"URL":"http:\/\/cdrjournal.com\/article\/view\/2823\/2471","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T08:42:32Z","timestamp":1705567352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oaepublish.com\/articles\/cdr.2018.12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":0,"URL":"https:\/\/doi.org\/10.20517\/cdr.2018.12","relation":{},"subject":[],"published":{"date-parts":[[2018]]}}}